结核病感染控制过程与临床影响之间的关键联系:需要有效性数据和MDR-TB特异性
Parth Aphale1, Shashank Dokania1, Himanshu Shekhar1
1Dr. D.Y. Patil Vidyapeeth (Deemed to be University), Pimpri, Pune, Maharashtra, India.
Journal of clinical tuberculosis and other mycobacterial diseases
|December 24, 2025
概括
这项研究表明,中国医院的结核病感染控制 (TBIC) 实施有所改善. 然而,它质疑较高的比率是否真正反映了对公共卫生的影响,特别是对多药耐药结核病 (MDR-TB) 的影响.
科学领域:
- 公共卫生 公共卫生
- 传染病流行病学 传染病流行病学
- 医疗保健管理的管理
背景情况:
- 结核病仍然是一个重大的全球卫生挑战,需要有效的感染控制策略.
- 高负担的环境需要强大的结核病感染控制 (TBIC) 计划来控制疾病.
- 之前的研究强调了在各种医疗环境中评估TBIC干预措施的需要.
研究的目的:
- 评估方案干预措施对TBIC实施率的可行性和影响.
- 评估遵守行政控制 (AC),环境控制 (EC) 和呼吸道保护 (RP) 的情况.
- 批判性地研究TBIC实施率与公共卫生结果之间的相关性,特别是针对多药耐药结核病 (MDR-TB).
主要方法:
- 来自指定医院的TBIC实施数据的回顾性分析.
- 对AC,EC和RP措施的合规率的定量评估.
- 观察到的TBIC改善对公共卫生影响的定性评估.
主要成果:
- 总体TBIC实施率有显著的改善.
- 记录了对行政控制 (AC),环境控制 (EC) 和呼吸道保护 (RP) 的遵守程度的提高.
- 这项研究强调了对直接公共卫生影响的进一步调查的需要.
结论:
- 方案性干预可以在高负担环境中可行地提高TBIC实施率.
- 虽然提高合规性是积极的,但测量公共卫生影响需要进一步评估.
- 结核病治疗的有效性,特别是对MDR-TB的有效性,需要继续研究和改进评估指标.
相关概念视频
01:26Pulmonary Tuberculosis IV
467
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
467
01:28Pulmonary Tuberculosis V
520
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
520
01:29Pulmonary Tuberculosis I
801
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
801
01:28Pulmonary Tuberculosis II
1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
01:29Therapeutic Drug Monitoring: Affecting Factors
170
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
170
01:31Pulmonary Tuberculosis III
884
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
884